Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines
Clinical trial NCT05592223 · COMPLETED
Trial details
- NCT number
- NCT05592223
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-06
- Primary completion
- 2023-08-23
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.